- Home
- INDV vs PK Comparison
INDV vs PK Comparison
Compare INDV & PK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INDV
- PK
- Stock Information
- Founded
- INDV 1994
- PK 1946
- Country
- INDV United States
- PK United States
- Employees
- INDV N/A
- PK N/A
- Industry
- INDV Biotechnology: Pharmaceutical Preparations
- PK Real Estate Investment Trusts
- Sector
- INDV Health Care
- PK Real Estate
- Exchange
- INDV Nasdaq
- PK Nasdaq
- Market Cap
- INDV 1.9B
- PK 2.1B
- IPO Year
- INDV N/A
- PK N/A
- Fundamental
- Price
- INDV $24.98
- PK $12.00
- Analyst Decision
- INDV Strong Buy
- PK Hold
- Analyst Count
- INDV 4
- PK 11
- Target Price
- INDV $23.75
- PK $12.95
- AVG Volume (30 Days)
- INDV 2.1M
- PK 3.4M
- Earning Date
- INDV 10-23-2025
- PK 10-30-2025
- Dividend Yield
- INDV N/A
- PK 11.56%
- EPS Growth
- INDV N/A
- PK N/A
- EPS
- INDV 0.42
- PK 0.28
- Revenue
- INDV $1,173,000,000.00
- PK $2,589,000,000.00
- Revenue This Year
- INDV N/A
- PK $1.88
- Revenue Next Year
- INDV $3.00
- PK $2.52
- P/E Ratio
- INDV $59.99
- PK $43.46
- Revenue Growth
- INDV 2.27
- PK N/A
- 52 Week Low
- INDV $7.33
- PK $8.27
- 52 Week High
- INDV $25.00
- PK $16.23
- Technical
- Relative Strength Index (RSI)
- INDV 80.77
- PK 64.01
- Support Level
- INDV $23.59
- PK $11.43
- Resistance Level
- INDV $25.00
- PK $12.01
- Average True Range (ATR)
- INDV 0.68
- PK 0.30
- MACD
- INDV -0.18
- PK 0.06
- Stochastic Oscillator
- INDV 98.96
- PK 76.55
About INDV Indivior PLC
Indivior PLC is a specialty and generic drug manufacturing company. The company is focused on the development, manufacture, and sale of prescription drugs for treatment of substance use disorders and other serious mental illnesses. Its products include, Sublocade, Perseris, Suboxone, Opvee among others. The vast majority of Indivior's revenue is generated in the United States, followed by United Kingdom and the rest of the world.
About PK Park Hotels & Resorts Inc.
Park Hotels & Resorts owns upper-upscale and luxury hotels with 22,711 rooms across 37 hotels in the United States. Park also has interests through joint ventures in another 2,271 rooms in three US hotels. Park was spun out of narrow-moat Hilton Worldwide Holdings at the start of 2017, so most of the company's hotels are still under Hilton brands. The company has sold all its international hotels and many of its lower-quality US hotels to focus on high-quality assets in domestic gateway markets.